INTRODUCTION
============

In response to action potential--induced depolarization, Ca~V~1.1 serves in skeletal muscle as the voltage-sensing apparatus that initiates excitation--contraction coupling and additionally produces L-type Ca^2+^ current ([@bib37]). Two distinct sizes of Ca~V~1.1 polypeptide have been identified in adult rabbit skeletal muscle ([@bib5]). The first, an ∼212-kD full-length translation product, is less abundant than the ∼175-kD form that is produced posttranslationally from the full-length protein by cleavage of the C terminus. Via mass spectrometry, the site of cleavage has been found to occur between alanine1664 and asparagine1665 ([@bib20]). Additionally, analysis of Ca~V~1.1 fragments expressed in tsA-201 and yeast cells led to the hypothesis that the cleaved distal C terminus remains noncovalently associated with the rest of the channel ([@bib20]), and that the binding of an A kinase--anchoring protein (AKAP)15 to a modified leucine zipper within the distal C terminus recruits PKA to the Ca~V~1.1-containing channel complex ([@bib18]). Comparable experiments suggested that a similar arrangement might occur in cardiac muscle between Ca~V~1.2 and its distal C terminus ([@bib6]; [@bib21]), and between its distal C terminus, AKAP15, and PKA ([@bib19]).

The functional consequences of C-terminal truncation have been examined by heterologous expression of full-length and truncated Ca~V~1.1 and Ca~V~1.2 constructs. In *Xenopus laevis* oocytes, where the posttranslational proteolytic cleavage of the full-length proteins presumably does not occur, constructs encoding full-length Ca~V~1.1 ([@bib28]) and Ca~V~1.2 ([@bib39]) have lower estimated open probability (P~o~) than those encoding the truncated proteins. In tsA-201 cells, for which it has been directly demonstrated that full-length Ca~V~1.2 is not proteolytically cleaved ([@bib21]), full-length Ca~V~1.2 likewise has lower P~o~ than truncated constructs ([@bib13]; [@bib21]). Based on these and other results, it has been proposed that the distal C terminus functions as an autoinhibitory subunit of both Ca~V~1.1 ([@bib20]) and Ca~V~1.2 ([@bib21]). Furthermore, it has been proposed that this autoinhibition is relieved for Ca~V~1.2 in cardiomyocytes by activation of the β-adrenergic pathway ([@bib12]), and for Ca~V~1.1 in skeletal muscle cells in response to strong depolarization.

Depolarization-induced potentiation is displayed by L-type Ca^2+^ currents produced both by Ca~V~1.1 ([@bib35]; [@bib22], [@bib23]) and Ca~V~1.2 ([@bib31]; [@bib34]). Moreover, it has been suggested that this potentiation contributes to increased entry of Ca^2+^ per action potential in response to increased firing rate in both skeletal ([@bib35]) and cardiac ([@bib34]) muscle. Analysis of single-channel currents for Ca~V~1.2 has shown that strong and/or prolonged depolarization causes the channel to enter a state with increased open dwell time, which has been termed "mode 2" gating ([@bib31]). At the macroscopic level, this entry into mode 2 gating has the consequence that increasing the amplitude or duration of a depolarizing pulse causes the tail currents that result from a subsequent repolarization both to be larger and to decay more slowly.

In contrast to the results obtained in nonmuscle cells, we earlier found ([@bib4]) that P~o~ did not differ for full-length or truncated Ca~V~1.1 constructs after expression in dysgenic myotubes (null for endogenous Ca~V~1.1), which raises the possibility that the Ca~V~1.1 distal C terminus might not function in an autoinhibitory manner within a native skeletal muscle environment. Thus, in the experiments described here, we have reexamined, in skeletal muscle cells, the posttranslational truncation of Ca~V~1.1 and its functional consequences. The experiments made use of immunoprecipitation of native Ca~V~1.1 in neonatal mouse muscle, imaging of fluorescently tagged Ca~V~1.1 constructs expressed in adult mouse muscle in vivo, and functional analysis of full-length or truncated constructs after expression in dysgenic myotubes. The results do not support the idea that the distal C terminus is required for depolarization-induced potentiation or that it associates noncovalently with proximal Ca~V~1.1.

MATERIALS AND METHODS
=====================

Myotube cultures, Western blotting, and immunoprecipitation
-----------------------------------------------------------

Normal and dysgenic myotubes were cultured as described previously ([@bib37]; [@bib2]). For biochemical measurements, the dissociated myoblasts were plated at a density of 2 × 10^6^ per 10--cm dish and for electrophysiology at a density of 10^5^ within an ∼1-cm circle scratched into the bottom of a 35-mm dish. To prepare myotube membranes, a 3× rinse of the 10-cm culture dishes with Ca^2+^-Mg^2+^ free rodent Ringer's solution (mM: 155 NaCl, 5 KCl, and 10 HEPES, pH 7.4, with NaOH) was followed by the addition of 1 ml of 0.3% digitonin in detergent buffer (mM: 100 NaCl and 50 Tris-HCl, pH 7.4). The myotubes were scraped from the dish with a rubber policeman and then homogenized (see below).

Fore- and hind-limb muscle were dissected on ice from mice of varying ages, frozen on dry ice, stored at −80°C, and subsequently homogenized with an Ultra-Turrax (Janke and Kunkel) in an ice-cold buffer (mM: 20 Na~4~P~2~O~7~, 20 NaH~2~PO~4~, 2.5 EGTA, and 300 sucrose) containing protease inhibitors (µg/ml: 10 aprotinin, 190 iodoacetamide, 50 N-α-tosyl-[l]{.smallcaps}-lysine chloromethyl ketone hydrochloride, 10 leupeptin, 40 phenylmethanesulfonyl-fluoride, 100 benzamidine, 14 pepstatin A, and 2 antipain). The homogenate was centrifuged at 1,500 *g* for 10 min at 4°C, and the supernatant was collected and pooled with the supernatant that resulted when the pellet was resuspended and subjected to the same centrifugation. Membranes in the pooled supernatants were pelleted by centrifugation at 100,000 *g* at 4°C for 60 min and resuspended in 1% digitonin in detergent buffer. Both the muscle membranes and the scraped myotubes (see above) were subjected to 15 passes with a type A pestle in a Dounce homogenizer (Bellco Glass), and then kept on ice for an additional 30 min, followed by centrifugation at 100,000 *g* at 4°C to pellet insoluble material. Aliquots for SDS PAGE were denatured in Laemmli sample buffer with 5% β-mercaptoethanol and placed in a boiling water bath for 30 s.

The IIF7 monoclonal antibody ([@bib26]) was provided by K. Campbell (University of Iowa School of Medicine, Iowa City, IA). Aliquots of the lyophilized ascites were reconstituted to their original volume and stored at −20°C before use. To generate the distal antibody, a polypeptide corresponding to residues 1,819--1,834 of Ca~V~1.1 (compare [Fig. 1](#fig1){ref-type="fig"}), with a cysteine added to the N terminus, was synthesized and purified by HPLC and, after conjugation to maleimide-activated keyhole limpet hemocyanin (Thermo Fisher Scientific), was used to immunize rabbits (procedures performed by the Macromolecular Resource Facility at Colorado State University). The antibody was purified by means of an affinity column containing agarose beads (Pierce SulfoLink; Thermo Fisher Scientific) to which the immunizing peptide had been conjugated by its N-terminal cysteine. The resulting antibody was ineffective for Western blotting but was effective for immunoprecipitation. For blocked antibody experiments, the distal antibody was incubated for 2 h at room temperature with 200 µg of the immunizing peptide to a final peptide/antibody molar ratio of 100:1.

For immunoprecipitation, the solubilized muscle and myotube membranes were diluted to reduce the concentration of digitonin to 0.1% in detergent buffer and mixed with the antibodies: 85 µg/ml of the distal antibody or 1:50 of IIF7 ascites (for IIF7, SDS was also present at a final concentration of 0.2%). After overnight incubation at 4°C with rotational mixing, protein G agarose, which had been equilibrated with the immunoprecipitation buffer, was added at 50 µl/ml, and rotational mixing continued for an additional 4--6 h. The beads were spun down at 1,500 *g* for 5 min. The pellet was then washed twice, resuspended in Laemmli sample buffer containing 5% β-mercaptoethanol, placed in a boiling water bath for 2 min, and cooled and centrifuged in an Eppendorf microfuge for 5 min at 10,000 rpm, and the supernatant was retained.

Electrophoresis was performed on a 5% gel, followed by wet transfer to a nitrocellulose membrane (50 V for 2 h). After a 2-h incubation in blocking buffer (5% wt/vol nonfat dry milk in Tris-buffered saline, pH 7.4, with 0.1% tween \[TBS-T\]), the membrane was incubated overnight in blocking buffer with 1:5,000 IIF7 ascites fluid, washed once for 15 min and four times for 5 min in TBS-T, incubated in 1:5,000 horseradish peroxidase--conjugated goat anti--mouse IgG for 90 min, and visualized by means of enhanced chemiluminescence.

cDNA constructs
---------------

The construction of the plasmids YFP-Ca~V~1.1~1860~ (YFP, 15-residue linker, rabbit Ca~V~1.1 residues 1--1,860, 14 nonnative residues, and a stop), YFP-Ca~V~1.1~1666~ (YFP, 15-residue linker, Ca~V~1.1 residues 1--1,666, 13 nonnative residues, and a stop), CFP-YFP-Ca~V~1.1 (CFP, 23-residue linker, YFP, 15-residue linker, Ca~V~1.1 residues 1--1,860, 14 nonnative residues, and a stop), and YFP-Ca~V~1.1-CFP (YFP, 15-residue linker, Ca~V~1.1 residues 1--1,860, 13 nonnative residues, and CFP) was essentially as described previously ([@bib27]; [@bib30]). Full-length rabbit Ca~V~1.1 has 1,873 residues (SwissProt accession no. [P07293](P07293); [@bib36]).

In vivo electroporation, dissociation, and imaging of flexor digitorum brevis (FDB) fibers
------------------------------------------------------------------------------------------

cDNA plasmids were delivered to FDB fibers of anesthetized 3-mo-old male C57BL/6J mice (The Jackson Laboratory) via an in vivo electroporation protocol similar to that originally described by [@bib7]. In brief, the FDB muscle was injected via a 30-gauge needle with 10 µl of 2 mg/ml hyaluronidase solution and 1 h later with 20 µl cDNA (3--5 µg/µl). 5 min later, cDNAs were electroporated into the muscle with 20 100-V, 20-ms pulses delivered at 1 Hz via two gold-plated acupuncture needles (TCG20 × 25; Lhasa OMS) placed subcutaneously near the proximal and distal tendons (∼10 mm apart). Transfected and nontransfected FDB muscles were dissected in cold rodent Ringer's solution (mM: 146 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, and 10 HEPES, pH 7.4 with NaOH). Muscles were then digested in 2% collagenase (Roche) in minimum essential medium (Gibco) with 10% fetal bovine serum (Hyclone) with agitation at 37°C for ∼60 min. Immediately after digestion, the collagenase solution was replaced with minimum essential medium without collagenase, and the muscles were triturated gently with a series of fire-polished glass pipettes of descending bore. Dissociated FDB fibers were allowed to settle onto laminin-coated 35-mm culture dishes with glass coverslip bottoms (MatTek) for 1--4 h at 37°C, 5% CO~2~.

The dissociated transfected fibers were imaged in rodent Ringer's solution with either an LSM510 or LSM710 confocal microscope (Carl Zeiss). For CFP, excitation was either 458 nm (LSM510) or 440 nm (LSM710), and emission was either 465--495 nm (LSM510) or 455--495 nm (LSM710). For YFP, excitation was 514 nm, and emission was either 530 nm long-pass (LSM510) or 520--580 nm (LSM710). For quantitative comparison of fluorescence emission intensities between cells, the photomultiplier gains were kept identical, although it was usually necessary to vary the laser excitation intensities to obtain good images. Control experiments demonstrated that the ratio of (fluorescence intensity)/(laser intensity) was constant as long as there was no saturation of the A/D converter. Thus, before comparison, fluorescence intensities were scaled offline to account for differences in laser excitation.

Electrophysiological analysis of endogenous Ca~V~1.1 in normal muscle cells, and YFP-Ca~V~1.1~1860~ and YFP-Ca~V~1.1~1666~ in dysgenic myotubes
-----------------------------------------------------------------------------------------------------------------------------------------------

Dysgenic myotubes, which lack endogenous Ca~V~1.1 ([@bib24]), were microinjected ([@bib2]) in single nuclei with 200 ng/µl cDNA for YFP-Ca~V~1.1~1860~ or YFP-Ca~V~1.1~1666~. Expressing cells were positively identified 48 h after injection by yellow fluorescence.

Macroscopic currents were obtained using the whole-cell patch-clamp technique ([@bib16]). Patch pipettes, which were constructed using borosilicate glass and filled with an "internal solution" (mM: 140 CsAsp, 5 MgCl~2~, 10 Cs~2~EGTA, and 10 HEPES, pH 7.4 with CsOH), had resistances of 1.7--2.2 MΩ for myotubes and \<1 MΩ for dissociated FDB fibers. Although the internal solution lacked ATP, myotubes subjected to whole-cell patch clamping with this solution retain the ability for upwards of 30 min to release Ca^2+^ from the sarcoplasmic reticulum and to resequester it ([@bib1]), which implies the continuing presence of sufficient myoplasmic ATP to support robust activity of the sarcoplasmic reticulum Ca^2+^ pump. The external solution contained (mM): 10 CaCl~2~, 145 tetraethylammonium-Cl, 0.003 tetrodotoxin, and 10 HEPES, pH 7.4 with tetraethylammonium-OH.

In myotubes, test currents were obtained by stepping from the holding potential (−80 mV) to −30 mV for 1 s (to inactivate endogenous T-type Ca^2+^ current) to −50 mV for 25 ms, and then to more positive test potentials; currents in FDB fibers were elicited by stepping directly from the holding potential to the test potential. Test currents were corrected for linear components of leak and capacitive current by digitally scaling and subtracting the average of eight control currents each elicited by a 20-mV hyperpolarization from the holding potential. The current evoked by a 20-mV hyperpolarizing step was also used to calculate linear cell capacitance. Calcium currents were sampled either at 1 kHz or, for tail currents, at 10 kHz, filtered at 0.5 and 5 kHz, respectively. Currents as a function of test potential were fitted according to:$$I\left( V \right) = {G_{max}}^{*}{\left( {V - V_{rev}} \right)/\left\{ {1 + exp\left\lbrack {- \left( {V - V_{1/2}} \right)/k} \right\rbrack} \right\}},$$where *I(V)* is the peak inward Ca^2+^ current measured at test potential *V*, *G~max~* is the maximal Ca^2+^ conductance, *V~rev~* is the reversal potential, *V*~1/2~ is the potential for half-activation, and *k* is a slope factor.

Potentiation was assessed by measuring the peak amplitude (I) and half-decay time (T) of tail currents produced by repolarization after 200-ms test pulses ranging from 40 to 90 mV in 10-mV increments, or after a 90-mV depolarization ranging in duration from 50 to 200 ms in 50-ms increments. To ensure both that the tail current decay was complete within 20 ms, and that it was not so rapid that the tail currents could not be well resolved, the repolarization potential varied between cells (−20 mV for Ca~V~1.1~1860~, from −20 to −40 mV for Ca~V~1.1~1666~, and −30 mV for native Ca~V~1.1). In individual cells, however, the relative changes in tail current amplitude and decay were always calculated as ratios for a single repolarization potential (e.g., the amplitude of the tail current after the 90-mV prepulse divided by the amplitude of the tail current after the 40-mV prepulse, both measured at the same repolarization potential). One would not expect these ratios to depend on the repolarization potential, but we directly verified this in control experiments on several cells. Cells were allowed to recover for ∼2 s at −80 mV between each depolarization--repolarization combination.

Analysis
--------

Figures were made using the software program SigmaPlot (version 11.0; SSPS Inc.). All data are presented as mean ± SEM. Statistical comparisons were made by unpaired, two-tailed *t* test or ANOVA (as appropriate), with P \< 0.05 considered significant.

RESULTS
=======

Developmental regulation of Ca~V~1.1 C-terminal truncation
----------------------------------------------------------

[Fig. 1](#fig1){ref-type="fig"} illustrates an alignment of the Ca~V~1.1 C terminus from rabbit and mouse skeletal muscle, together with an indication of regions that have been reported to be important for its posttranslational processing in rabbit. As an initial approach for investigating the posttranslational processing of Ca~V~1.1 in mouse, we used the monoclonal antibody IIF7, which has an epitope mapped to residues 956--1,005 (Campbell, K.P., personal communication). Because this region differs between mouse and rat by only two residues and is upstream of the C-terminal truncation site ([Fig. 1](#fig1){ref-type="fig"}, red arrow), IIF7 would be predicted to detect Ca~V~1.1 in mouse independent of any posttranslational processing of the C terminus. Consistent with this prediction, Western blots with IIF7 revealed that wild-type myotubes contain two sizes of Ca~V~1.1 ([Fig. 2 A](#fig2){ref-type="fig"}), which differed in mass by about the amount expected (∼20 kD) if C-terminal truncation in mouse occurred at the same site as in rabbit. Note that each of the two sized forms appeared to a variable extent as doublets, which we found to be an artifact of the heat denaturation of the samples. The IIF7-reactive bands were absent in dysgenic myotubes (leftmost lane, [Fig. 2 A](#fig2){ref-type="fig"}), supporting the conclusion that they represent Ca~V~1.1.

![Alignment of C termini of Ca~V~1.1 from rabbit (SwissProt accession no. [P07293.1](P07293.1); blue font) and mouse (SwissProt accession no. [Q02789](Q02789)), with introduced gaps indicated by asterisks. Residues 1,381--1,570 are identical for the two sequences. Residues of the mouse sequence that differ from those of rabbit are indicated by cyan highlighting. The sites of posttranslational truncation of rabbit Ca~V~1.1 ([@bib20]) and the termination of rabbit sequence for our construct YFP-Ca~V~1.1~1666~ are indicated by red and black arrows, respectively. The black arrowhead indicates the final native residue of the constructs YFP-Ca~V~1.1~1860~ and YFP-Ca~V~1.1-CFP, and the bracket indicates the peptide sequence used to generate the "Distal" antibody. The domains of the rabbit distal C terminus proposed to bind AKAP ([@bib18], [@bib20]) and to mediate binding to proximal Ca~V~1.1 (distal C terminus interaction domain; [@bib20]) are indicated by green and red lines, respectively. Residues of rabbit Ca~V~1.1 shown to be phosphorylated by PKA in vivo ([@bib32]; [@bib9]) are highlighted in yellow.](JGP_201411292_Fig1){#fig1}

A clear trend, which is evident in [Fig. 2 A](#fig2){ref-type="fig"}, was that the relative abundance of the larger Ca~V~1.1 protein decreased as a function of in vitro developmental age, an effect that was also present in the averaged data ([Fig. 2 B](#fig2){ref-type="fig"}). The decreasing relative abundance of the larger Ca~V~1.1 was even more pronounced for muscle developing in vivo, declining from ∼30% in the first few days after birth to \<10% after about 1 mo ([Fig. 2 C](#fig2){ref-type="fig"}). This latter is comparable to the fraction of full-length Ca~V~1.1 reported previously for adult rabbit skeletal muscle ([@bib5]). Thus, the posttranslational truncation of Ca~V~1.1 appears to be similar in mouse and rabbit.

![Developmental changes in expression of full-length and truncated Ca~V~1.1. (A) Western blots of membranes isolated from wild-type myotubes grown in culture for the indicated number of days (denoting plating as "Day 1") and probed with the IIF7 monoclonal antibody, which recognizes both the full-length and truncated species. The leftmost lane illustrates membranes from dysgenic (Ca~V~1.1-null) myotubes. Based on scanning densitometry, full-length Ca~V~1.1 as a fraction of total (full-length plus truncated) is plotted as a function of developmental age in vitro (B) and in vivo (C). Error bars indicate SEM, and numbers of cultures or mice are indicated in parentheses. In B, myotubes from 4--5 d were grouped and plotted at day 4.5. In C, mice of 1--3, 5--9, 13--18, and 21--30 d, respectively, were grouped and plotted at time points corresponding to the average age of each group.](JGP_201411292_Fig2){#fig2}

Apparent lack of interaction in muscle cells between the distal Ca~V~1.1 C-terminal and proximal domains of the channel
-----------------------------------------------------------------------------------------------------------------------

To examine further the relationship between the two sizes of mouse Ca~V~1.1, we generated an antibody against a peptide corresponding to a sequence that is downstream from the rabbit truncation site and is conserved between rabbit and mouse ([Fig. 1](#fig1){ref-type="fig"}, "distal Ab"). [Fig. 3](#fig3){ref-type="fig"} compares immunoprecipitation of digitonin-solubilized neonatal muscle membranes with either IIF7 ("Proximal") or the distal antibody. With IIF7, both the larger and smaller Ca~V~1.1 polypeptides were immunoprecipitated, whereas only the larger polypeptide was immunoprecipitated by the distal antibody. This result demonstrates that the larger polypeptide contains the distal C terminus (i.e., essentially full-length), whereas the shorter polypeptide lacks the distal C terminus (i.e., truncated). However, the results illustrated in [Fig. 3](#fig3){ref-type="fig"} have an additional implication. Specifically, if the cleaved distal C terminus had been bound to the truncated proximal channel, then the distal antibody should have immunoprecipitated both the truncated and nontruncated polypeptides. That this did not occur suggests that the distal C terminus does not bind to the truncated channel in muscle cells.

![IIF7, which has an epitope proximal to the truncation site, immunoprecipitates both sized species of Ca~V~1.1, whereas the distal antibody only immunoprecipitates the larger species. Solubilized P1 muscle membranes were immunoprecipitated with either IIF7 (lanes 1 and 2) or with the distal antibody (lanes 3 and 4), or with the distal antibody preincubated with its generating peptide (lanes 5 and 6). Western blotting of the resulting pellets and supernatants with IIF7 demonstrates that the distal epitope is present only in the larger-sized form of Ca~V~1.1. Note that lanes 3--6 are all from the same experiment, that lanes 3 and 5 were loaded identically, and that lanes 4 and 6 were loaded identically.](JGP_201411292_Fig3){#fig3}

It is possible that the experiment shown in [Fig. 3](#fig3){ref-type="fig"} failed to detect an interaction between the distal C terminus and proximal Ca~V~1.1 because this interaction was disturbed by digitonin, or that this proposed interaction masked the epitope for the distal antibody. Thus, we also tested for the interaction by electroporating FDB fibers of adult mice with a construct encoding Ca~V~1.1 with a CFP-YFP tandem attached to the N terminus (CFP-YFP-Ca~V~1.1), or with YFP attached to the N terminus and CFP attached to residue 1,860 of the C-terminus (YFP-Ca~V~1.1-CFP). Subsequently, images were obtained of dissociated fibers displaying a striated yellow fluorescence pattern consistent with a t-tubular localization of the Ca~V~1.1 construct. [Fig. 4](#fig4){ref-type="fig"} illustrates the patterns observed in one fiber transfected with CFP-YFP-Ca~V~1.1 ([Fig. 4 A](#fig4){ref-type="fig"}) and in two fibers transfected with YFP-Ca~V~1.1-CFP ([Fig. 4, B and C](#fig4){ref-type="fig"}). Fluorescence intensity profiles for these three fibers, within the indicated regions of interest, are shown in [Fig. 4](#fig4){ref-type="fig"} (A′, B′, and C′). The fiber transfected with CFP-YFP-Ca~V~1.1 displayed colocalized yellow and cyan fluorescence (indicated by red and green, respectively; [Fig. 4, A and A′](#fig4){ref-type="fig"}); similar colocalized striations were present in two fibers dissociated 9 d after transfection with CFP-YFP-Ca~V~1.1 and nine fibers dissociated 14 d after transfection. In contrast, the fibers expressing YFP-Ca~V~1.1-CFP displayed yellow striations like those of fibers expressing CFP-YFP-Ca~V~1.1, but not colocalized striations of cyan fluorescence ([Fig. 4, B, B′, C, and C′](#fig4){ref-type="fig"}). Rather, some fibers in which YFP-Ca~V~1.1-CFP was highly expressed displayed obvious cyan fluorescent striations that were offset from the yellow fluorescence ([Fig. 4, B and B′](#fig4){ref-type="fig"}), which is the pattern that would be produced if the CFP-tagged distal C terminus had been cleaved and accumulated in the I-bands adjacent to the t-tubules. In other fibers expressing YFP-Ca~V~1.1-CFP at a lower level ([Fig. 4, C and C′](#fig4){ref-type="fig"}), both the yellow and cyan fluorescence were weaker, and the offset striations of cyan fluorescence were either less pronounced or not discernible. Altogether, images were obtained from a total of 11 fibers expressing YFP-Ca~V~1.1-CFP at either 9 d (three fibers) or 14 d (eight fibers). Out of these 11 fibers, offset cyan striations (like those of [Fig. 4, B and C](#fig4){ref-type="fig"}) were present in seven (two at 9 d and five at 14 d), and low level cyan fluorescence with an indeterminate distribution was present in four (one at 9 d and three at 14 d).

![Confocal fluorescence images representative of the patterns observed for CFP-YFP-Ca~V~1.1 (A) or YFP-Ca~V~1.1-CFP (B and C) obtained 2 wk after transfection of adult mouse FDB muscle; the yellow and cyan fluorescence are illustrated in red and green, respectively. The images were obtained with identical photomultiplier settings on an LSM710 confocal microscope; the corresponding average intensity profiles, within the indicated regions of interest, are illustrated in A′, B′, and C′, with the horizontal and vertical axes corresponding to micrometer and average pixel intensity (×10^−3^), respectively. The intensities in B′ and C′ were scaled according to the ratio of laser intensity (for B or C) to corresponding laser intensity (for A). Thus, the intensity profiles indicate that, compared with the cell illustrated in A and A′, the expression of Ca~V~1.1 was about threefold higher in B and B′ and ∼1.5-fold higher in C and C′. Calibration bar, 5 µm for all panels.](JGP_201411292_Fig4){#fig4}

Based on the results shown in [Figs. 2](#fig2){ref-type="fig"}--[4](#fig4){ref-type="fig"}, it appears that in adult skeletal muscle (a) the majority of the distal C terminus is cleaved, as also indicated by the data in [Fig. 2 C](#fig2){ref-type="fig"}; and (b) after cleavage, the distal C terminus does not remain associated with proximal domains of Ca~V~1.1.

Deletion of \>200 residues from the distal C terminus of Ca~V~1.1 does not alter L-type Ca^2+^ channel activity
---------------------------------------------------------------------------------------------------------------

To test the functional consequences of C-terminal truncation, we performed electrophysiological measurements. [Fig. 5 A](#fig5){ref-type="fig"} illustrates representative whole-cell Ca^2+^ currents after depolarization to the indicated potentials from dysgenic myotubes expressing YFP-Ca~V~1.1~1860~ (top) or YFP-Ca~V~1.1~1666~ (bottom). Based on average peak current versus voltage relationships ([Fig. 5 B](#fig5){ref-type="fig"}), the currents were of virtually identical amplitude and voltage dependence in dysgenic myotubes expressing YFP-Ca~V~1.1~1666~ or YFP-Ca~V~1.1~1860~. This result is in agreement with earlier results demonstrating that estimated P~o~ after expression in dysgenic myotubes differs little between untagged Ca~V~1.1, which is full-length or truncated at residue 1662 ([@bib4]). Moreover, the attachment of a fluorescent protein to the N terminus does not seem to have much effect on channel function because estimated P~o~ for Ca~V~1.1 N-terminally tagged with GFP ([@bib15]) is similar to that of untagged Ca~V~1.1 ([@bib4]).

![Ca^2+^ currents produced by expression in dysgenic myotubes of rabbit YFP-Ca~V~1.1~1860~ or of YFP-Ca~V~1.1~1666~ lacking the distal C terminus. In vivo, proteolytic cleavage has been reported to sever after residue 1,664 ([@bib20]). (A) Representative currents from dysgenic myotubes expressing cDNA encoding either YFP-Ca~V~1.1~1860~ (top) or YFP-Ca~V~1.1~1666~ (bottom), elicited by 200-ms depolarization to the indicated potentials. (B) Average peak current versus voltage relationships for YFP-Ca~V~1.1~1860~ (●) and YFP-Ca~V~1.1~1666~ (◆), with the number of experiments given in parentheses. The smooth curves represent plots of [Eq. 1](#fd1){ref-type="disp-formula"}, with the average values determined by best fits to the data from individual cells. Error bars indicate ± SEM.](JGP_201411292_Fig5){#fig5}

The distal C terminal of Ca~V~1.1 is not necessary for depolarization-induced potentiation of L-type Ca^2+^ current
-------------------------------------------------------------------------------------------------------------------

To analyze the depolarization-induced potentiation of the skeletal L-type Ca^2+^ current, we used two voltage protocols that were similar to those used in previous work ([@bib22], [@bib23]). In one protocol ([Fig. 6 A](#fig6){ref-type="fig"}, top), 200-ms steps to increasingly depolarized potentials were applied, followed by repolarization to elicit inward tail current. In the other protocol ([Fig. 6 B](#fig6){ref-type="fig"}, top), the duration of a depolarization to 90 mV was varied from 50 to 200 ms, before repolarization. As shown in [Fig. 6](#fig6){ref-type="fig"}, tail current amplitude was increased and decay time slowed when the prepulse depolarization was made either larger ([Fig. 6, A and B](#fig6){ref-type="fig"}) or longer ([Fig. 6, C and D](#fig6){ref-type="fig"}). This behavior is similar to that described previously for myotubes produced from the 129CB3 line of immortalized mouse myoblasts ([@bib22], [@bib23]). Importantly, the effects of increased prepulse amplitude, and of increased prepulse duration, were qualitatively similar in dysgenic myotubes expressing either Ca~V~1.1~1860~ or Ca~V~1.1~1666~.

![Potentiation by strong depolarization is qualitatively similar for Ca~V~1.1~1860~ and Ca~V~1.1~1666~. Potentiation was assayed by measuring tail currents upon repolarization to −20 mV after 200-ms prepulses of varying potential (A and B), or after prepulses to 90 mV of varying duration (C and D). These protocols are illustrated at the top of the figure, and the prepulse potentials or durations are indicated adjacent to the tail currents. Increasing either the potential or duration of the prepulse caused tail current amplitude to increase and decay to slow in a similar manner for dysgenic myotubes expressing cDNA encoding either Ca~V~1.1~1860~ (A and C) or Ca~V~1.1~1666~ (B and D).](JGP_201411292_Fig6){#fig6}

Four different quantities were used to compare depolarization-induced potentiation in dysgenic myotubes expressing YFP-Ca~V~1.1~1860~ or YFP-Ca~V~1.1~1666~. These were: (1) I~90~/I~40~, where the numerator and denominator represent peak inward tail currents elicited by repolarization after a 200-ms depolarization to either 90 or 40 mV ([Fig. 7 A1](#fig7){ref-type="fig"}); (2) I~200~/I~50~, where the numerator and denominator represent peak inward tail currents elicited by repolarization after a 90-mV depolarization of either 200 or 50 ms ([Fig. 7 B1](#fig7){ref-type="fig"}); (3) T~90~/T~40~, where the numerator and denominator represent half-decay times of tail currents elicited by repolarization after a 200-ms depolarization to either 90 or 40 mV ([Fig. 7 A2](#fig7){ref-type="fig"}); and (4) T~200~/T~50~, where the numerator and denominator represent half-decay times of tail currents elicited by repolarization after a 90-mV depolarization of either 200 or 50 ms ([Fig. 7 B2](#fig7){ref-type="fig"}). There was no statistically significant difference (P \> 0.05) in any of these four measures between dysgenic myotubes expressing YFP-Ca~V~1.1~1860~ or YFP-Ca~V~1.1~1666~.

![Potentiation is quantitatively similar for Ca~V~1.1~1860~ and Ca~V~1.1~1666~. Both the amplitude (I) and half-decay time (T) were measured for tail currents upon repolarization after either 200-ms prepulses to 40 or 90 mV (A1 and A2), or after 90-mV prepulses of 50- or 200-ms duration (B1 and B2). The number of cells examined is indicated in parentheses. There were no statistically significant differences between Ca~V~1.1~1860~ and Ca~V~1.1~1666~ based on a rank-sum test (I~90~/I~40~, P = 0.205; I~200~/I~50~, P = 1.0) or *t* test (T~90~/T~40~, P = 0.486; T~200~/T~50~, P = 0.289). Tail current repolarization potential was −20 mV for Ca~V~1.1~1860~ and ranged from −20 to −40 mV for Ca~V~1.1~1666~ (see Materials and methods).](JGP_201411292_Fig7){#fig7}

In addition to examining the effects of truncation by comparing dysgenic myotubes after transfection with YFP-Ca~V~1.1~1860~ or YFP-Ca~V~1.1~1666~, we also compared potentiation in muscle fibers from neonatal and 30-d postnatal mice. Over this time period, there was a greater than fourfold decease in the fraction of full-length Ca~V~1.1 ([Fig. 2 C](#fig2){ref-type="fig"}). However, as shown in [Fig. 8](#fig8){ref-type="fig"}, depolarization-induced potentiation did not differ significantly in fibers from neonatal and 30-d postnatal mice.

![Potentiation is quantitatively similar for native Ca~V~1.1 in muscle fibers of neonatal (day 0 and day 1) mice and 1-mo-old mice. Potentiation was quantified as illustrated in [Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"} for tail currents produced by repolarization to −30 mV (number of cells in parentheses). *t* test comparisons of potentiation in dissociated FDB muscle fibers from neonatal and 1-mo-old mice yielded P = 0.23 for I~90~/I~40~ (A1), P = 0.39 for T~90~/T~40~ (A2), P = 0.90 for I~200~/I~50~ (B1), and P = 0.19 for T~200~/T~50~ (B2).](JGP_201411292_Fig8){#fig8}

DISCUSSION
==========

In this study, we examined the posttranslational processing of the Ca~V~1.1 C terminus, and whether the distal C terminus is required for depolarization-induced potentiation of the L-type Ca^2+^ current in skeletal muscle. In agreement with previous work ([@bib5]), we found two different sizes of Ca~V~1.1, with the smaller one constituting the majority (\>90%) in adult mouse skeletal muscle; additionally, we found that relative abundance of this smaller form increased during postnatal development ([Fig. 2](#fig2){ref-type="fig"}). Based on immunoprecipitation, the larger form contains a "distal" epitope which is \<50 residues from the predicted termination of mouse Ca~V~1.1 ([Fig. 1](#fig1){ref-type="fig"}), whereas the smaller form lacks this epitope ([Fig. 3](#fig3){ref-type="fig"}), which is consistent with the idea that truncation of mouse Ca~V~1.1 is homologous to that experimentally determined for rabbit Ca~V~1.1 ([@bib20]; [Fig. 1](#fig1){ref-type="fig"}). Two experimental approaches indicated that the distal portion of the C terminus does not remain noncovalently bound to proximal Ca~V~1.1. First, an antibody to the distal epitope immunoprecipitated only the larger sized Ca~V~1.1 from neonatal mouse muscle ([Fig. 3](#fig3){ref-type="fig"}). Second, colocalized cyan and yellow fluorescence were not observed after in vivo expression in adult FDB fibers of YFP-Ca~V~1.1-CFP ([Fig. 4](#fig4){ref-type="fig"}). Rather, the yellow fluorescence appeared to reflect a t-tubular location, whereas the cyan fluorescence was that which would be expected if proteolytic cleavage had allowed the movement of the distal C terminus into the myoplasm (predominantly within the I band). Functionally, the analysis of myotubes indicated that the distal C terminus was not important for depolarization-induced potentiation of Ca~V~1.1 In particular, depolarization-induced potentiation was similar for YFP-Ca~V~1.1~1860~ and YFP-Ca~V~1.1~1666~ expressed in dysgenic myotubes ([Fig. 7](#fig7){ref-type="fig"}). Additionally, depolarization-induced potentiation differed little between neonatal and postnatal day 30 muscle fibers ([Fig. 8](#fig8){ref-type="fig"}), despite the large change in C-terminal truncation that occurred over this time period ([Fig. 2](#fig2){ref-type="fig"}). Because Ca~V~1.1 can undergo depolarization-induced potentiation without the distal C-terminal domain, it would appear that this potentiation does not require either phosphorylation of serine 1854 or AKAP tethering, within this domain ([Fig. 1](#fig1){ref-type="fig"}).

For our analysis of fluorescently tagged Ca~V~1.1 expressed in FDB muscles ([Fig. 4](#fig4){ref-type="fig"}), we primarily examined fibers 2 wk after electroporation, which we selected because it was the earliest of the times used in a previous study of FDB fibers electroporated with Ca~V~1.1 cDNAs ([@bib8]). Based on Western blotting and the measurement of calcium currents, charge movements, and excitation--contraction coupling Ca^2+^ release, DiFranco et al. concluded that in fibers 2--7 wk after electroporation, the exogenously expressed Ca~V~1.1 constructs replaced the majority of the endogenous Ca~V~1.1 and functionally interacted with RyR1, and that total Ca~V~1.1 content (exogenous plus endogenous) was only modestly elevated (37%) compared with fibers that had not been electroporated. Thus, their work implies that the posttranslational processing of the exogenous Ca~V~1.1 constructs is similar to that of endogenous Ca~V~1.1.

Because the intensity profiles illustrated for YFP-Ca~V~1.1-CFP in [Fig. 4 (B′ and C′)](#fig4){ref-type="fig"} were scaled relative to that for CFP-YFP-Ca~V~1.1 ([Fig. 4 A′](#fig4){ref-type="fig"}) to account for differences in laser excitation intensity, the yellow intensity profiles in the three panels should be directly comparable to one another, as should the cyan intensity profiles. Furthermore, if CFP and YFP are assumed to be equimolar in fibers expressing CFP-YFP-Ca~V~1.1, then the ratio of the cyan to yellow fluorescence in [Fig. 4 (B′ and C′)](#fig4){ref-type="fig"} should reflect the abundance of the CFP-tagged C terminus relative to that of the YFP-tagged proximal Ca~V~1.1. (The agreement in the average yellow and cyan intensities in [Fig. 4 A′](#fig4){ref-type="fig"} is a consequence of the specific laser and photomultiplier settings used, and does not directly imply an equimolar presence of CFP and YFP.) However, if CFP and YFP are assumed equimolar in fibers expressing CFP-YFP-Ca~V~1.1, then the cyan and yellow intensity profiles in B′ and C′ provide a direct estimate of the abundance of the CFP moiety relative to that of the YFP moiety in these two fibers expressing YFP-Ca~V~1.1-CFP. By this interpretation, the spatially averaged concentration of the CFP-tagged C-terminal fragment relative to the rest of the channel is ∼38 and ∼33% for the profiles in [Fig. 4 (B′ and C](#fig4){ref-type="fig"}, respectively). We have not investigated the mechanisms responsible for this loss of the CFP-tagged fragment, although proteolysis and diffusion into regions of the fibers not producing the YFP-Ca~V~1.1-CFP protein are both possibilities. Nonetheless, one might expect that the residual level of CFP-tagged C terminus would have been sufficient to result in colocalized CFP and YFP striations if it had bound to the proximal channel. Of course, we cannot exclude the possibility that the stability of the postulated interaction between the distal C terminus and proximal Ca~V~1.1 was affected by the presence of the C-terminal fluorescent protein.

Comparison with other studies of Ca~V~1.1 potentiation
------------------------------------------------------

To compare our results on Ca~V~1.1 potentiation with those of previous studies, it is necessary to take differences of experimental conditions into account. For example, [@bib23] used an external solution containing 10 mM Ba^2+^ to measure tail currents at −80 mV after 500-ms depolarizations ranging from −40 mV up to either 60 or 80 mV. Tail current amplitudes and decay times were found to increase over this entire range, presumably as a result of increasing contributions from: (a) "OFF"-gating currents largely attributable to Ca~V~1.1; (b) inward ionic (Ba^2+^) current resulting from the increasing activation of nonpotentiated Ca~V~1.1 channels; and (c) inward ionic currents produced by potentiated Ca~V~1.1 channels. To examine voltage-dependent potentiation of Ca~V~1.1, in our work, we used a less negative repolarization potential. We also tried to minimize contributions (a) and (b) by comparing tail currents after depolarizing test potentials above 40 mV (where both OFF-gating currents and conventional \[nonpotentiated\] activation are near or at saturation under our experimental conditions; compare [@bib1]). We found that for neonatal muscle fibers, I~90~/I~40~ ([Fig. 8 A1](#fig8){ref-type="fig"}) and T~90~/T~40~ ([Fig. 8 A2](#fig8){ref-type="fig"}) had values of ∼2.8 and ∼1.5, respectively. By way of comparison, [@bib23] found that tail current amplitude and time constant for tail current decay in mouse myotubes increased ∼1.7-fold and approximately twofold, respectively, over the most comparable voltage range illustrated in their Fig. 2 C (between 10 and 60 mV). It should be noted that because 10 mM Ba^2+^ produces an ∼10-mV hyperpolarizing shift in the activation of current via Ca~V~1.1 compared with 10 mM Ca^2+^ ([@bib3]), those voltages would correspond approximately to 20 and 70 mV under our experimental conditions. Thus, the potentiation by strong depolarization found in our work appears to be in reasonably good quantitative agreement with that found by [@bib23].

[@bib23] additionally determined how tail current amplitudes and decay times were affected by varying the duration of an 80-mV prepulse from 5 to 75 ms, whereas we varied a 90-mV prepulse from 50 to 200 ms. We chose these longer durations because one might reasonably expect that between 5 and 50 ms, the increasing activation of Ca~V~1.1 liter-type current (compare [Fig. 5 A](#fig5){ref-type="fig"}) would cause a large change in the subsequent tail currents, even if there were no potentiation occurring over this time interval. Nonetheless, the fold-change found by [@bib23] in tail current amplitude (∼1.4) and decay time (∼2) for control mouse myotubes between 50 and 75 ms (closed circles in their Fig. 3, C and D) are roughly comparable to the values that we found of ∼1.7 for I~200~/I~50~ ([Fig. 8 B1](#fig8){ref-type="fig"}) and of ∼1.5 for T~200~/T~50~ ([Fig. 8 B2](#fig8){ref-type="fig"}).

The effects of strong depolarization on Ca^2+^ currents in mouse myotubes has also been examined with a much different protocol ([@bib18]). Specifically, a "conditioning sequence," which consisted of a 200-ms potentiating prepulse to 100 mV followed by a 25-ms repolarization to −60 mV, was applied before depolarizing test pulses to varying levels. The presence of this intervening hyperpolarization, which would cause channels to deactivate, means that the subsequent test pulse assayed channels that were predominantly closed, unlike the tail current protocol used by us and by [@bib23], which assayed channels that were open at the end of the potentiating prepulse. When [@bib18] compared currents for the test depolarizations that were preceded by the conditioning sequence, with currents elicited by the identical depolarizations applied directly from the holding potential (−80 mV), they found that the effects of the conditioning sequence depended strongly on test potential (their Fig. 6). Specifically, the test currents were increased for test potentials within the negative slope region of the peak I-V relationship (roughly −20 to 10 mV, with the biggest effect at more negative potentials) but were little altered for test potentials ≥20 mV. This behavior indicates that the phenomenon studied by [@bib18] is mechanistically different from that characterized here and in [@bib23]. Indeed, we found that when potential was stepped directly from a strongly depolarizing prepulse, current amplitudes increased greatly when the subsequent pulse was either to a hyperpolarized level ([Fig. 6](#fig6){ref-type="fig"}) or to a depolarized level (30 mV; Fig. 4 e of [@bib38]).

Is full-length Ca~V~1.1 present in the plasma membrane?
-------------------------------------------------------

Ca~V~1.1 channel P~o~'s have been estimated from measurements of peak ionic currents and of gating charge movements (the latter as an indicator of membrane expression). With this approach, estimated P~o~ was found not to differ after expression in dysgenic myotubes of cDNAs encoding full-length or truncated (at residue 1662) Ca~V~1.1 ([@bib4]). One possible explanation for the similarity of estimated P~o~ is that even when myotubes are transfected with cDNA encoding full-length Ca~V~1.1, truncation occurs before insertion into the plasma membrane. However, an argument against this idea is provided by experiments in which a Ca~V~1.1-GFP construct was transiently expressed in dysgenic myotubes ([@bib10]), followed by fixation, permeabilization, and double immunostaining with a monoclonal antibody against the Ca~V~1.1 II--III loop ([@bib25]) and an anti-GFP polyclonal antibody. With this approach, staining with the two antibodies was observed to colocalize in discrete puncta, as would be produced by the membrane insertion of full-length channels, but the methodology does not provide a quantitative estimate of what fraction of membrane-inserted Ca~V~1.1 was full-length and what fraction was truncated. However, if the experiments on *Xenopus* oocytes are taken as a guide, it would seem that the fraction of membrane-inserted, full-length Ca~V~1.1 must be quite small. In particular, estimated P~o~ is about fivefold lower for full-length rabbit Ca~V~1.1 expressed in *Xenopus* oocytes than for Ca~V~1.1 truncated at residue 1697 ([@bib28]). If this also applied to myotubes and if half of all Ca~V~1.1 in the membrane were full-length, then estimated P~o~ would be 40% lower after expression of full-length Ca~V~1.1 in myotubes than after expression of truncated Ca~V~1.1, which is clearly not the case ([@bib4]). However, if the fraction of full-length Ca~V~1.1 were relatively small (20%, say), then the estimated P~o~ would be reduced only ∼15%, which would make it difficult to distinguish between myotubes transfected with full-length or truncated constructs. Of course, one must also take into account that the regulation of P~o~ differs between myotubes and oocytes. For example, RyR1, which is present in myotubes but not in oocytes, causes an approximate threefold increase in P~o~ of the endogenous Ca~V~1.1 Ca^2+^ channels in mouse myotubes ([@bib29]).

Whether or not full-length channels can insert into the plasma membrane, our results make it clear that depolarization-induced potentiation can occur in the complete absence of the distal C terminus. Moreover, potentiation was quantitatively similar for YFP-Ca~V~1.1~1860~ and YFP-Ca~V~1.1~1666~ ([Fig. 7](#fig7){ref-type="fig"}). In principle, potentiation of YFP-Ca~V~1.1~1860~ could differ from that of full-length Ca~V~1.1 because of the absence of the final 13 residues. However, it seems unlikely that these terminal residues are of major importance, as there is only modest conservation of sequence in this region between rabbit and mouse Ca~V~1.1 ([Fig. 1](#fig1){ref-type="fig"}), and potentiation of Ca^2+^ current in wild-type mouse FDB muscle fibers ([Fig. 8](#fig8){ref-type="fig"}) is not much different from that in dysgenic myotubes expressing the rabbit constructs ([Fig. 7](#fig7){ref-type="fig"}).

Biological role of Ca~V~1.1 distal C terminus
---------------------------------------------

Our current results raise once again the question of the role of the distal C terminus of Ca~V~1.1. In particular, a truncated Ca~V~1.1 is able to function as both L-type Ca^2+^ channel and voltage sensor for excitation--contraction coupling ([@bib4]), and to undergo depolarization-induced potentiation, without need for the distal segment of the C terminus ([Figs. 6](#fig6){ref-type="fig"}--[8](#fig8){ref-type="fig"}). It is possible that the distal C terminus is important for the regulation of Ca^2+^ current via Ca~V~1.1 in response to β-adrenergic activation of the PKA pathway in skeletal muscle, as has been proposed for Ca~V~1.2 in heart ([@bib12]). However, the effect of activating PKA in skeletal muscle appears to be very modest, amounting to 25% or less in mouse myotubes ([@bib11]; [@bib17]). Furthermore, we could find no evidence of an association in muscle cells between the distal C terminus and proximal Ca~V~1.1, as probed both by immunoprecipitation and by expression of fluorescently tagged Ca~V~1.1. In light of these results, one could postulate that the primary role of the distal C terminus is to act as a regulator of the insertion of Ca~V~1.1 into the plasma membrane (i.e., that its removal promotes this insertion). This hypothesis might account for why the C-terminal sequence is conserved between mouse and rabbit in the region surrounding the site of posttranslational truncation, but not for why there is also considerable conservation within the distal C terminus of the proposed AKAP-binding domain and the "distal C terminus interaction domain," as indicated by the green and red lines, respectively, in [Fig. 1](#fig1){ref-type="fig"}. Thus, it seems likely that there are other biological roles for the distal C terminus. One possibility is that it functions as a transcriptional regulator, as has been suggested for the distal C terminus of Ca~V~1.2 ([@bib14]; [@bib33]). Alternatively, it might help to regulate the insertion and removal pathways that govern the homeostasis of Ca~V~1.1 levels in the plasma membrane. Exploration of these potential roles would be aided by information about where and how the posttranslational truncation occurs and perhaps by creation of knock-in mice with a stop codon placed at the truncation site.
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